{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T09:22:47Z","timestamp":1789982567810,"version":"4.0.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,6,16]],"date-time":"2017-06-16T00:00:00Z","timestamp":1497571200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,6,16]],"date-time":"2017-06-16T00:00:00Z","timestamp":1497571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Angiopoietin-1 (Angpt1) is a glycoprotein ligand important for maintaining the vascular system. It signals via a receptor tyrosine kinase expressed on the surface on endothelial cells, Tie2. This receptor can undergo regulated ectodomain cleavage that releases the ligand-binding domain (sTie2) into the circulation. The concentration of sTie2 is increased in a range of conditions, including peripheral arterial disease and myocardial infarction, where it has been suggested to bind and block Angpt1 resulting in vascular dysfunction. Here we use a joint mathematical modelling and experimental approach to assess the potential impact of sTie2 on the ability of Angpt1 to signal. We find that the concentrations of sTie2 relative to Angpt1 required to suppress signalling by the ligand are more than ten\u2013fold higher than those ever seen in normal or disease conditions. In contrast to the endogenous sTie2, an engineered form of sTie2, which presents dimeric ligand binding sites, inhibits Angpt1 signalling at seventy-fold lower concentrations. While loss of Tie2 ectodomain can suppress Angpt1 signalling locally in the cells in which the receptor is lost, our study shows that the resulting increase in circulating sTie2 is unlikely to affect Angpt1 activity elsewhere in the body.<\/jats:p>","DOI":"10.1038\/s41598-017-03981-6","type":"journal-article","created":{"date-parts":[[2017,6,12]],"date-time":"2017-06-12T09:34:50Z","timestamp":1497260090000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Regulation of Angiopoietin Signalling by Soluble Tie2 Ectodomain and Engineered Ligand Trap"],"prefix":"10.1038","volume":"7","author":[{"given":"Deborah O. A.","family":"Alawo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tariq A.","family":"Tahir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlies","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Declan G.","family":"Bates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana R.","family":"Amirova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas P. J.","family":"Brindle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,16]]},"reference":[{"key":"3981_CR1","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/nrm2639","volume":"10","author":"HG Augustin","year":"2009","unstructured":"Augustin, H. G., Young Koh, G., Thurston, G. & Alitalo, K. Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system. Nat. Rev. Mol. Cell. Biol. \n                           10, 165\u2013177, doi:10.1038\/nrm2639 (2009).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"3981_CR2","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1073\/pnas.96.5.1904","volume":"96","author":"DM Valenzuela","year":"1999","unstructured":"Valenzuela, D. M. et al. Angiopoietins 3 and 4: Diverging gene counterparts in mice and humans. Proc. Natl. Acad. Sci. USA. \n                           96, 1904\u20131909, doi:10.1073\/pnas.96.5.1904 (1999).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"3981_CR3","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1126\/science.277.5322.55","volume":"277","author":"PC Maisonpierre","year":"1997","unstructured":"Maisonpierre, P. C. et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science \n                           277, 55\u201360, doi:10.1126\/science.277.5322.55 (1997).","journal-title":"Science"},{"key":"3981_CR4","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/S0092-8674(00)81812-7","volume":"87","author":"S Davis","year":"1996","unstructured":"Davis, S. et al. Isolation of angiopoietin-1, a ligand for the Tie2 receptor, by secretion-trap expression cloning. Cell \n                           87, 1161\u20131169, doi:10.1016\/S0092-8674(00)81812-7 (1996).","journal-title":"Cell"},{"key":"3981_CR5","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1161\/01.RES.0000218275.54089.12","volume":"98","author":"NPJ Brindle","year":"2006","unstructured":"Brindle, N. P. J., Saharinen, P. & Alitalo, K. Signaling and functions of angiopoietin-1 in vascular protection. Circ. Res. \n                           98, 1014\u20131023, doi:10.1161\/01.RES.0000218275.54089.12 (2006).","journal-title":"Circ. Res."},{"key":"3981_CR6","first-page":"71","volume":"7","author":"DJ Dumont","year":"1992","unstructured":"Dumont, D. J. et al. Tek, a novel tyrosine kinase gene located on mouse chromosome 4, is expressed in endothelial cells and their presumptive precursors. Oncogene \n                           7, 71\u201380 (1992).","journal-title":"Oncogene"},{"key":"3981_CR7","first-page":"99","volume":"9","author":"AS Runting","year":"1993","unstructured":"Runting, A. S., Stacker, S. A. & Wilks, A. F. Tie2, a putative protein tyrosine kinase from a new class of cell surface receptor. Growth Factors \n                           9, 99\u2013105 (1993).","journal-title":"Growth Factors"},{"key":"3981_CR8","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1023\/A:1012226627813","volume":"4","author":"P Reusch","year":"2001","unstructured":"Reusch, P. et al. Identification of a soluble form of the angiopoietin receptor Tie-2 released from endothelial cells and present in human blood. Angiogenesis \n                           4, 123\u2013131, doi:10.1023\/A:1012226627813 (2001).","journal-title":"Angiogenesis"},{"key":"3981_CR9","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1161\/ATVBAHA.107.150482","volume":"27","author":"CM Findley","year":"2007","unstructured":"Findley, C. M., Cudmore, M. J., Ahmed, A. & Kontos, C. D. VEGF induces Tie2 shedding via a phosphoinositide 3-kinase\/akt-dependent pathway to modulate Tie2 signaling. Arterioscler. Thromb. Vasc. Biol. \n                           27, 2619\u20132626, doi:10.1161\/ATVBAHA.107.150482 (2007).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"3981_CR10","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1161\/01.CIR.0000138112.90641.7F","volume":"110","author":"KW Lee","year":"2004","unstructured":"Lee, K. W., Lip, G. Y. & Blann, A. D. Plasma angiopoietin-1, angiopoietin-2, angiopoietin receptor Tie-2, and vascular endothelial growth factor levels in acute coronary syndromes. Circulation \n                           110, 2355\u20132360, doi:10.1161\/01.CIR.0000138112.90641.7F (2004).","journal-title":"Circulation"},{"key":"3981_CR11","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1046\/j.1365-2362.2003.01173.x","volume":"33","author":"NA Chung","year":"2003","unstructured":"Chung, N. A., Makin, A. J. & Lip, G. Y. Measurement of the soluble angiopoietin receptor Tie-2 in patients with coronary artery disease: Development and application of an immunoassay. Eur. J. Clin. Invest. \n                           33, 529\u2013535, doi:10.1046\/j.1365-2362.2003.01173.x (2003).","journal-title":"Eur. J. Clin. Invest."},{"key":"3981_CR12","first-page":"1","volume":"33","author":"C Wang","year":"2005","unstructured":"Wang, C. et al. Soluble angiopoietin receptor Tie-2 in patients with acute myocardial infarction and its effects on angiogenesis. Clin. Hemorheol. Microcirc. \n                           33, 1\u201310 (2005).","journal-title":"Clin. Hemorheol. Microcirc."},{"key":"3981_CR13","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.jacc.2003.08.042","volume":"43","author":"AY Chong","year":"2004","unstructured":"Chong, A. Y. et al. Plasma angiopoietin-1, angiopoietin-2, and angiopoietin receptor Tie-2 levels in congestive heart failure. J. Am. Coll. Cardiol. \n                           43, 423\u2013428, doi:10.1016\/j.jacc.2003.08.042 (2004).","journal-title":"J. Am. Coll. Cardiol."},{"key":"3981_CR14","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/01.WCB.0000037547.46809.83","volume":"23","author":"K-M Scheufler","year":"2003","unstructured":"Scheufler, K.-M. et al. Implications of vascular endothelial growth factor, sFlt-1, and sTie-2 in plasma, serum and cerebrospinal fluid during cerebral ischemia in man. J. Cereb. Blood Flow Metab. \n                           23, 99\u2013110, doi:10.1097\/01.WCB.0000037547.46809.83 (2003).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"3981_CR15","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.jacc.2008.02.045","volume":"52","author":"CM Findley","year":"2008","unstructured":"Findley, C. M. et al. Plasma levels of soluble Tie2 and vascular endothelial growth factor distinguish critical limb ischemia from intermittent claudication in patients with peripheral arterial disease. J. Am. Coll. Cardiol. \n                           52, 387\u2013393, doi:10.1016\/j.jacc.2008.02.045 (2008).","journal-title":"J. Am. Coll. Cardiol."},{"key":"3981_CR16","doi-asserted-by":"publisher","first-page":"R63","DOI":"10.1186\/cc11309","volume":"16","author":"T Wada","year":"2012","unstructured":"Wada, T. et al. Using angiogenic factors and their soluble receptors to predict organ dysfunction in patients with disseminated intravascular coagulation associated with severe trauma. Crit. Care \n                           16, R63, doi:10.1186\/cc11309 (2012).","journal-title":"Crit. Care"},{"key":"3981_CR17","doi-asserted-by":"publisher","first-page":"R171","DOI":"10.1186\/cc11648","volume":"16","author":"T Wada","year":"2012","unstructured":"Wada, T. et al. Angiogenic factors and their soluble receptors predict organ dysfunction and mortality in post-cardiac arrest syndrome. Crit. Care \n                           16, R171, doi:10.1186\/cc11648 (2012).","journal-title":"Crit. Care"},{"key":"3981_CR18","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1111\/j.1468-3083.2011.04012.x","volume":"25","author":"S Noda","year":"2011","unstructured":"Noda, S. et al. Serum Tie2 levels: Clinical association with microangiopathies in patients with systemic sclerosis. J. Eur. Acad. Dermatol. Venereol \n                           25, 1476\u20131479, doi:10.1111\/j.1468-3083.2011.04012.x (2011).","journal-title":"J. Eur. Acad. Dermatol. Venereol"},{"key":"3981_CR19","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/j.1365-2362.2006.01602.x","volume":"36","author":"IE Koutroubakis","year":"2006","unstructured":"Koutroubakis, I. E. et al. Potential role of soluble angiopoietin-2 and Tie-2 in patients with inflammatory bowel disease. Eur. J. Clin. Invest. \n                           36, 127\u2013132, doi:10.1111\/j.1365-2362.2006.01602.x (2006).","journal-title":"Eur. J. Clin. Invest."},{"key":"3981_CR20","unstructured":"Cornish-Bowden, A. Fundamentals of Enzyme Kinetics. (Wily-Blackwell, 2012)."},{"key":"3981_CR21","doi-asserted-by":"publisher","first-page":"20126","DOI":"10.1074\/jbc.M500292200","volume":"280","author":"K-T Kim","year":"2005","unstructured":"Kim, K.-T. et al. Oligomerization and multimerization is critical for angiopoietin-1 to bind and phosphorylate Tie2. J. Biol. Chem. \n                           280, 20126\u201320131, doi:10.1074\/jbc.M500292200 (2005).","journal-title":"J. Biol. Chem."},{"key":"3981_CR22","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nsb880","volume":"10","author":"S Davis","year":"2003","unstructured":"Davis, S. et al. Angiopoietins have distinct modular domains essential for receptor binding, dimerization and superclustering. Nat. Struct. Biol \n                           10, 38\u201344, doi:10.1038\/nsb880 (2003).","journal-title":"Nat. Struct. Biol"},{"key":"3981_CR23","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.devcel.2007.10.019","volume":"14","author":"J Gavard","year":"2008","unstructured":"Gavard, J., Patel, V. & Gutkind, J. S. Angiopoietin-1 prevents VEGF-induced endothelial permeability by sequestering Src through mDia. Dev. Cell \n                           14, 25\u201336, doi:10.1016\/j.devcel.2007.10.019 (2008).","journal-title":"Dev. Cell"},{"key":"3981_CR24","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0014-5793(99)00378-6","volume":"448","author":"HJ Kwak","year":"1999","unstructured":"Kwak, H. J. et al. Angiopoietin-1 is an apoptosis survival factor for endothelial cells. FEBS Lett \n                           448, 249\u2013253, doi:10.1016\/S0014-5793(99)00378-6 (1999).","journal-title":"FEBS Lett"},{"key":"3981_CR25","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1083\/jcb.201207009","volume":"199","author":"SP Ngok","year":"2012","unstructured":"Ngok, S. P. et al. VEGF and angiopoietin-1 exert opposing effects on cell junctions by regulating the Rho GEF Syx. J. Cell Biol. \n                           199, 1103\u20131115, doi:10.1083\/jcb.201207009 (2012).","journal-title":"J. Cell Biol."},{"key":"3981_CR26","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1210\/rp.59.1.51","volume":"59","author":"KG Peters","year":"2004","unstructured":"Peters, K. G. et al. Functional significance of Tie2 signaling in the adult vasculature. Recent Prog. Horm. Res. \n                           59, 51\u201371, doi:10.1210\/rp.59.1.51 (2004).","journal-title":"Recent Prog. Horm. Res."},{"key":"3981_CR27","doi-asserted-by":"publisher","first-page":"10243","DOI":"10.1021\/bi010959e","volume":"40","author":"BW Murray","year":"2001","unstructured":"Murray, B. W., Padrique, E. S., Pinko, C. & McTigue, M. A. Mechanistic effects of autophosphorylation on receptor tyrosine kinase catalysis: Enzymatic characterization of Tie2 and phospho-Tie2. Biochemistry \n                           40, 10243\u201310253, doi:10.1021\/bi010959e (2001).","journal-title":"Biochemistry"},{"key":"3981_CR28","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nm811","volume":"9","author":"AN Economides","year":"2003","unstructured":"Economides, A. N. et al. Cytokine traps: Multi-component, high-affinity blockers of cytokine action. Nat. Med \n                           9, 47\u201352, doi:10.1038\/nm811 (2003).","journal-title":"Nat. Med"},{"key":"3981_CR29","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1177\/106002809703101111","volume":"31","author":"KM Murray","year":"1997","unstructured":"Murray, K. M. & Dahl, S. L. Recombinant human tumor necrosis factor receptor (p75) Fc fusion protein (TNFR:Fc) in rheumatoid arthritis. Ann. Pharmacother. \n                           31, 1335\u20131338, doi:10.1177\/106002809703101111 (1997).","journal-title":"Ann. Pharmacother."},{"key":"3981_CR30","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1007\/s40265-015-0421-y","volume":"75","author":"GM Keating","year":"2015","unstructured":"Keating, G. M. Aflibercept: A review of its use in diabetic macular oedema. Drugs \n                           75, 1153\u20131160, doi:10.1007\/s40265-015-0421-y (2015).","journal-title":"Drugs"},{"key":"3981_CR31","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1471-2261-11-31","volume":"11","author":"C Iribarren","year":"2011","unstructured":"Iribarren, C. et al. Circulating angiopoietins-1 and -2, angiopoietin receptor Tie-2 and vascular endothelial growth factor-A as biomarkers of acute myocardial infarction: A prospective nested case-control study. BMC Cardiovasc. Disord. \n                           11, 31, doi:10.1186\/1471-2261-11-31 (2011).","journal-title":"BMC Cardiovasc. Disord."},{"key":"3981_CR32","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/j.1582-4934.2005.tb00341.x","volume":"9","author":"M Anghelina","year":"2005","unstructured":"Anghelina, M., Moldovan, L. & Moldovan, N. I. Preferential activity of Tie2 promoter in arteriolar endothelium. J. Cell. Mol. Med. \n                           9, 113\u2013121, doi:10.1111\/jcmm.2005.9.issue-1 (2005).","journal-title":"J. Cell. Mol. Med."},{"key":"3981_CR33","doi-asserted-by":"publisher","first-page":"3058","DOI":"10.1073\/pnas.94.7.3058","volume":"94","author":"TM Schlaeger","year":"1997","unstructured":"Schlaeger, T. M. et al. Uniform vascular-endothelial-cell-specific gene expression in both embryonic and adult transgenic mice. Proc. Natl. Acad. Sci. USA \n                           94, 3058\u20133063, doi:10.1073\/pnas.94.7.3058 (1997).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"3981_CR34","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/SHK.0b013e3181b2f978","volume":"33","author":"M van der Heijden","year":"2010","unstructured":"van der Heijden, M., van N Amerongen, G. P., van Hinsbergh, V. W. & Groeneveld, A. B. The interaction of soluble Tie2 with angiopoietins and pulmonary vascular permeability in septic and nonseptic critically ill patients. Shock \n                           33, 263\u2013268, doi:10.1097\/SHK.0b013e3181b2f978 (2010).","journal-title":"Shock"},{"key":"3981_CR35","doi-asserted-by":"publisher","first-page":"33205","DOI":"10.1074\/jbc.M113.510578","volume":"288","author":"NP Brindle","year":"2013","unstructured":"Brindle, N. P. et al. Directed evolution of an angiopoietin-2 ligand trap by somatic hypermutation and cell surface display. J. Biol. Chem. \n                           288, 33205\u201333212, doi:10.1074\/jbc.M113.510578 (2013).","journal-title":"J. Biol. Chem."},{"key":"3981_CR36","doi-asserted-by":"publisher","first-page":"e29319","DOI":"10.1371\/journal.pone.0029319","volume":"7","author":"H Singh","year":"2012","unstructured":"Singh, H., Hansen, T. M., Patel, N. & Brindle, N. P. J. The molecular balance between receptor tyrosine kinases Tie1 and Tie2 is dynamically controlled by VEGF and TNF\u03b1 and regulates angiopoietin signalling. PLoS One \n                           7, e29319, doi:10.1371\/journal.pone.0029319 (2012).","journal-title":"PLoS One"},{"key":"3981_CR37","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/0003-2697(85)90073-9","volume":"151","author":"JA Matthews","year":"1985","unstructured":"Matthews, J. A., Batki, A., Hynds, C. & Kricka, L. J. Enhanced chemiluminescent method for the detection of DNA dot-hybridization assays. Anal. Biochem. \n                           151, 205\u2013209, doi:10.1016\/0003-2697(85)90073-9 (1985).","journal-title":"Anal. Biochem."},{"key":"3981_CR38","doi-asserted-by":"publisher","first-page":"30509","DOI":"10.1074\/jbc.M702535200","volume":"282","author":"MB Marron","year":"2007","unstructured":"Marron, M. B. et al. Regulated proteolytic processing of Tie1 modulates ligand responsiveness of the receptor tyrosine kinase Tie2. J. Biol. Chem. \n                           282, 30509\u201330517, doi:10.1074\/jbc.M702535200 (2007).","journal-title":"J. Biol. Chem."},{"key":"3981_CR39","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/nsmb1101","volume":"13","author":"WA Barton","year":"2006","unstructured":"Barton, W. A. et al. Crystal structures of the Tie2 receptor ectodomain and the angiopoietin-2-tie2 complex. Nat. Struct. Mol. Biol. \n                           13, 524\u2013532, doi:10.1038\/nsmb1101 (2006).","journal-title":"Nat. Struct. Mol. Biol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-03981-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-03981-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-03981-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T05:36:55Z","timestamp":1671773815000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-03981-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,16]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["3981"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-03981-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,16]]},"assertion":[{"value":"22 February 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"3658"}}